Adagio Medical Holdings (ADGM) Cash from Financing Activities (2023 - 2024)
Adagio Medical Holdings (ADGM) posted Cash from Financing Activities of $5.1 million for Q2 2024, down 47.01% sequentially from $9.6 million in Q1 2024.
Adagio Medical Holdings (ADGM) Cash from Financing Activities (2023 - 2024) Analysis & Trends
Adagio Medical Holdings has reported Cash from Financing Activities for 2 years, with the latest figure at $5.1 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Adagio Medical Holdings | 14.47 Mn | 14.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | 5.07 Mn |
| Mar 31, 2024 | 9.57 Mn |
| Mar 31, 2024 | 9.57 Mn |
| Dec 31, 2023 | 6.58 Mn |
| Dec 31, 2023 | 6.58 Mn |